GE Healthcare Receives FDA Approval of First-Ever Software to Help Automate Anesthesia Delivery and Reduce Greenhouse Gas Emissions During Surgery

3 years ago

End-tidal Control software helps reduce greenhouse gas emissions and costs by cutting anesthetic agent waste Enables anesthesia providers to set…

SecurAcath® Receives Innovative Technology Contract From Vizient

3 years ago

PLYMOUTH, Minn.--(BUSINESS WIRE)--Interrad Medical, a privately held medical device company, announces its SecurAcath device has received an Innovative Technology contract…

Axonics® Launches Direct to Consumer Television Advertising Campaign

3 years ago

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the…

Kareo and PatientPop’s Combined Platform Leveraged by the Perdido Bay Medical Group to Deliver Integrated Care and Grow Business

3 years ago

All-in-One Solution Boosts Operations and Digital Footprint for New Practice in Alabama IRVINE, Calif.--(BUSINESS WIRE)--#Kareo--Kareo, a leading provider of cloud-based…

BridgeBio Pharma Presents Updated Results from Phase 2 Open-label Extension Study of Acoramidis in Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

3 years ago

- NT-proBNP, a biomarker of cardiac failure and independent predictor of mortality in ATTR-CM patients, was stable or improving throughout…

Junshi Biosciences Announces FDA Approval of Investigational New Drug Application for Anti-CD112R Monoclonal Antibody for Treatment of Advanced Solid Tumors

3 years ago

SHANGHAI, China, April 03, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a…

Sotagliflozin Improved Outcomes in Patients With and Without Prior Cardiovascular Disease in New Analysis Presented at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22)

3 years ago

Late-breaking presentation of analysis of SCORED clinical trial data describes significant reduction in cardiovascular death, myocardial infarction and stroke with…

Cytokinetics Announces Results From Cohort 3 of Redwood-HCM Presented at American College of Cardiology 71st Annual Scientific Session

3 years ago

Aficamten Reduced LVOT Gradients and Improved NYHA Class and NT-proBNP in Patients with Obstructive Hypertrophic Cardiomyopathy Treated with Disopyramide REDWOOD-HCM…

Core One Labs’ Akome Receives Positive Results from Bioassay Studies

3 years ago

Will Look to Advance its Psychedelic Based FormulationsVANCOUVER, British Columbia, April 02, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc.…

bioLytical Laboratories Inc. Receives Health Canada Authorization for the iStatis COVID-19 Antigen Home Test

3 years ago

iStatis COVID-19 Antigen Home Test the iStatis COVID-19 Antigen Home Test is Here! bioLytical Laboratories Inc. announced today that it…